Gene-Editing shot aims to slash stubborn cholesterol in High-Risk patients
NCT ID NCT06451770
First seen Jan 05, 2026 · Last updated May 16, 2026 · Updated 18 times
Summary
This early-phase study tests a single dose of VERVE-201, a gene-editing therapy, in 36 adults with high cholesterol and triglycerides that don't respond to standard treatments. The goal is to see if it is safe and to measure how it affects blood fat levels. Participants must not have chronic liver disease or be on certain other cholesterol-lowering drugs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTRIGLYCERIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Study Center
RECRUITINGAdelaide, Australia
-
Clinical Study Center
RECRUITINGMelbourne, Australia
-
Clinical Study Center
RECRUITINGChicoutimi, Canada
-
Clinical Study Center
RECRUITINGMontreal, Canada
-
Clinical Study Center
RECRUITINGToronto, Canada
-
Clinical Study Center
RECRUITINGCape Town, South Africa
-
Clinical Study Center
RECRUITINGJohannesburg, South Africa
-
Clinical Study Center
RECRUITINGLiverpool, United Kingdom
-
Clinical Study Center
RECRUITINGLondon, United Kingdom
-
Clinical Study Center
RECRUITINGManchester, United Kingdom
Conditions
Explore the condition pages connected to this study.